HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vemurafenib as a neoadjuvant therapy in advanced melanoma: local tumour control, but no prevention of metastatic relapse.

AuthorsMarie Tauber, Cécile Pages, Roberta La Selva, Pierre Schneider, Jacques Chardin, Amélie Osio, Samia Mourah, Stéphane Culine, Laetitia Vercellino, Martine Bagot, Celeste Lebbé
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2013 Sep-Oct Vol. 23 Issue 5 Pg. 702-3 ISSN: 1952-4013 [Electronic] France
PMID24135270 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Brain Neoplasms (drug therapy, secondary)
  • Humans
  • Indoles (therapeutic use)
  • Lymphatic Metastasis
  • Melanoma (drug therapy, secondary, surgery)
  • Neoadjuvant Therapy
  • Skin Neoplasms (drug therapy, pathology, surgery)
  • Sulfonamides (therapeutic use)
  • Vemurafenib

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: